ERBB2 and breast carcinoma: Using cDNA microarray analysis for gene expression profiling (GEP), Perou et al. [1] unveiled a distinctive “molecular portrait” of breast cancer representing five intrinsic subtypes with distinct clinical outcomes, i.e., luminal A, luminal B, HER2 overexpression, basal and normal-like tumors.